Seeing Is Believing

Currently out of the existing stock ratings of Justin Zelin, 52 are a BUY (94.55%), 3 are a HOLD (5.45%).
Analyst Justin Zelin, currently employed at BTIG, carries an average stock price target met ratio of 21.76% that have a potential upside of 42.77% achieved within 105 days.
Justin Zelin’s has documented 97 price targets and ratings displayed on 20 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on VKTX, Viking Therapeutics at 21-Sep-2025.
Analyst best performing recommendations are on LYRA (LYRA THERAPEUTICS ).
The best stock recommendation documented was for ABEO (ABEONA THERAPEUTICS) at 11/11/2020. The price target of $50 was fulfilled within 69 days with a profit of $17.5 (53.85%) receiving and performance score of 7.8.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$20
$14.52 (264.96%)
$20
19 days ago
(12-Oct-2025)
0/10 (0%)
$14.59 (269.69%)
Buy
$20
$14.52 (264.96%)
$19
2 months 17 days ago
(14-Aug-2025)
0/2 (0%)
$12.87 (180.50%)
Buy
$20
$14.52 (264.96%)
$21
5 months 16 days ago
(15-May-2025)
0/2 (0%)
$13.9 (227.87%)
Buy
$15
$9.52 (173.72%)
$15
7 months 8 days ago
(23-Mar-2025)
0/2 (0%)
$9.88 (192.97%)
Buy
$18
$12.52 (228.47%)
$18
1 years 3 days ago
(28-Oct-2024)
1/5 (20%)
$11.43 (173.97%)
61
Which stock is Justin Zelin is most bullish on?
Which stock is Justin Zelin is most reserved on?
What Year was the first public recommendation made by Justin Zelin?